GR3025014T3 - A pharmaceutical composition for the intranasal administration of hydroxocobalamin - Google Patents

A pharmaceutical composition for the intranasal administration of hydroxocobalamin

Info

Publication number
GR3025014T3
GR3025014T3 GR970402659T GR970402659T GR3025014T3 GR 3025014 T3 GR3025014 T3 GR 3025014T3 GR 970402659 T GR970402659 T GR 970402659T GR 970402659 T GR970402659 T GR 970402659T GR 3025014 T3 GR3025014 T3 GR 3025014T3
Authority
GR
Greece
Prior art keywords
hydroxocobalamin
pct
pharmaceutical composition
intranasal administration
date jun
Prior art date
Application number
GR970402659T
Other languages
English (en)
Inventor
Franciscus Wilhelmus He Merkus
Original Assignee
Franciscus Wilhelmus He Merkus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Franciscus Wilhelmus He Merkus filed Critical Franciscus Wilhelmus He Merkus
Publication of GR3025014T3 publication Critical patent/GR3025014T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
GR970402659T 1993-12-20 1997-10-14 A pharmaceutical composition for the intranasal administration of hydroxocobalamin GR3025014T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9301418A BE1007839A6 (nl) 1993-12-20 1993-12-20 Farmaceutische compositie voor de nasale toediening van hydroxocobalamine.
PCT/EP1994/001567 WO1995017164A1 (en) 1993-12-20 1994-05-13 A pharmaceutical composition for the intranasal administration of hydroxocobalamin

Publications (1)

Publication Number Publication Date
GR3025014T3 true GR3025014T3 (en) 1998-01-30

Family

ID=3887657

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402659T GR3025014T3 (en) 1993-12-20 1997-10-14 A pharmaceutical composition for the intranasal administration of hydroxocobalamin

Country Status (11)

Country Link
US (1) US5801161A (el)
EP (1) EP0735859B1 (el)
JP (1) JP3623962B2 (el)
AT (1) ATE156014T1 (el)
AU (1) AU6969994A (el)
BE (1) BE1007839A6 (el)
DE (1) DE69404675T2 (el)
DK (1) DK0735859T3 (el)
ES (1) ES2107832T3 (el)
GR (1) GR3025014T3 (el)
WO (1) WO1995017164A1 (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132757A (en) 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6426084B1 (en) * 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
JP2002533399A (ja) * 1998-12-28 2002-10-08 アラジー リミテッド エルエルシー アレルギー性疾患に対するシアノコバラミン（ビタミンｂ１２）の治療方法
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6458804B1 (en) 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US20030096748A1 (en) * 2001-06-04 2003-05-22 The Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US7041677B2 (en) * 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
US7208628B2 (en) * 2002-05-13 2007-04-24 Kansas State University Research Foundation Compositions and methods for the treatment of hepatitis C virus infection
US7074893B2 (en) * 2002-06-03 2006-07-11 Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US7404489B1 (en) 2003-03-04 2008-07-29 Qol Medical, Llc Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
US7229636B1 (en) 2003-03-04 2007-06-12 Nastech Pharmaceutical Company Inc. Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
US20050032740A1 (en) * 2003-08-06 2005-02-10 Balaji Venkataraman Vitamin compositions for the treatment and prevention of vascular disease and dementia
US20050032741A1 (en) * 2003-08-06 2005-02-10 Balaji Venkataraman Vitamin Compositions
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
WO2005065185A2 (en) * 2003-12-24 2005-07-21 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
US8202507B2 (en) * 2004-09-23 2012-06-19 The Regents Of The University Of California Assay for vitamin B12 absorption and method of making labeled vitamin B12
WO2007022345A2 (en) * 2005-08-17 2007-02-22 Fleming And Company, Pharmaceuticals Vitamin b12 nasal spray and method of use
KR20140101010A (ko) * 2006-06-23 2014-08-18 파 파마슈티컬, 인크. 비내 전달용 시아노코발라민 저점도 수성 제형
AU2014202415B2 (en) * 2006-06-23 2016-02-18 Par Pharmaceutical, Inc Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
CN101011409B (zh) * 2007-02-06 2010-08-11 浙江爱生药业有限公司 一种维生素b12滴鼻液组合物
AP3814A (en) * 2010-10-29 2016-09-30 Troikaa Pharmaceuticals Ltd Nasal compositions of vitamin b12
US9585908B1 (en) 2010-11-08 2017-03-07 Chromaceutical Advanced Technologies, Inc. Collyrium composition and method of using same
NL2010550C2 (en) 2012-11-30 2014-06-04 Klaas Alouis Riepma An intranasal pharmaceutical composition containing vitamin b12.
JP5797227B2 (ja) * 2013-05-21 2015-10-21 パル ファーマシューティカル， インコーポレーテッド 鼻内送達用シアノコバラミン低粘度水性製剤
ES2842523T3 (es) 2015-05-15 2021-07-14 Univ Michigan Regents Métodos y composiciones para el tratamiento de la artritis
NL2015506B1 (en) 2015-09-25 2017-04-20 Alouis Riepma Klaas Oral administration of Vitamin B12 dispersed in a hydrophobic continuous phase
WO2019094469A1 (en) 2017-11-07 2019-05-16 The Regents Of The University Of Michigan Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
GB202013645D0 (en) 2020-08-31 2020-10-14 Innotesto Bvba Pharmacetical compositions for the nasal administration of a colbalamin compound
JP7038448B1 (ja) * 2021-07-19 2022-03-18 雅行 沼田 抗アレルギー用投与デバイス

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788780A (fr) * 1971-09-21 1973-01-02 Rolland Sa A Procede pour le diagnostic de l'hypercyanurie
US4724231A (en) * 1985-04-16 1988-02-09 Nastech Pharmaceutical, Inc. Nasel compositions containing vitamin B12
ATE70180T1 (de) * 1985-04-16 1991-12-15 Nastech Pharm Co Aerosolmittel zur nasenverstaeubung von vitamin b 12.

Also Published As

Publication number Publication date
BE1007839A6 (nl) 1995-10-31
AU6969994A (en) 1995-07-10
ES2107832T3 (es) 1997-12-01
WO1995017164A1 (en) 1995-06-29
US5801161A (en) 1998-09-01
JPH09507477A (ja) 1997-07-29
DK0735859T3 (da) 1998-03-09
ATE156014T1 (de) 1997-08-15
DE69404675T2 (de) 1997-11-27
EP0735859B1 (en) 1997-07-30
JP3623962B2 (ja) 2005-02-23
DE69404675D1 (de) 1997-09-04
EP0735859A1 (en) 1996-10-09

Similar Documents

Publication Publication Date Title
GR3025014T3 (en) A pharmaceutical composition for the intranasal administration of hydroxocobalamin
PL312441A1 (en) New pharmaceutical compositions
GB9426252D0 (en) Pharmaceutical composition
HUT72081A (en) Pharmaceutical compositions containing the combination of a cholesterol biosynthesis inhibitor and a beta-lactam cholesterol absorption inhibitor and their production
PT99513A (pt) Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica
IL108234A0 (en) Pharmaceutical composition containing galanthamine
IL127919A0 (en) Stabilized pharmaceutical compositions containing buproprion
HK1002017A1 (en) Lyospheres comprising gonadotropin
IL110045A0 (en) Pharmaceutical compositions containing oligopeptides combating aids and arc and for immune stimulation and certain such novel oligopeptides
IL113566A0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
AU1890295A (en) Piperidines and pyrrolidines
ZA966163B (en) Novel galanthamine derivatives, process for the preparation thereof, their application as medical drugs, and pharmaceutical compositions containing said derivatives.
GB9424766D0 (en) Pharmaceutical composition
NZ239022A (en) Piperidyl ethers and thioethers; preparatory processes and pharmaceutical compositions
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
IL105454A0 (en) Water-soluble retinoids,their preparation and pharmaceutical and cosmetic compositions containing them
AU5662996A (en) Compounds and compositions for delivering active agents
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them